Using ultrasound to improve diagnosis of oral cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the diagnostic process for oral squamous cell carcinoma by utilizing ultra-high frequency intraoral ultrasonography. The approach focuses on providing a minimally invasive imaging technique that can visualize anatomical structures beyond the mucosal surface, which is currently a limitation in standard clinical examinations. By integrating this advanced ultrasound technology into routine diagnostics, the study seeks to improve the accuracy and efficiency of identifying oral neoplasms. The methodology involves clinical diagnosis confirmation and eligibility for surgical treatment as key criteria for participant selection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical diagnosis of oral squamous cell carcinoma
* Eligibility for surgical treatment
* Acceptance to be included in the study

Exclusion Criteria:

* Oral lesions other than oral squamous cell carcinoma
* Pregnant or breastfeeding patients
* Uncontrolled chronic diseases and/or conditions hindering the participation in the study
* Denial of inclusion in the study

Where it's running

• Università di Pisa
  Pisa, Italy Recruiting

Study contacts

• Study coordinator: Rossana Izzetti, DDS, PhD
• Email: rossana.izzetti@unipi.it
• Phone: +39050993037

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Salivary IL-8 and Serum IL-6 as Biomarkers to Distinguish Oral Premalignant Disorders in Smokers and Never-Smokers

  This study tests whether salivary IL-8 and blood IL-6 can help tell apart adults with oral premalignant conditions from those with healthy mouths, and whether smoking influences these markers.

  Recruiting British University In Egypt · Cairo · NCT07915570

• Docetaxel and SX-682 in head and neck cancers and prostate cancer

  This trial tests a new drug SX-682 together with docetaxel in adults whose head and neck cancers or prostate cancer have returned or spread.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07667400

• Patient-specific 3D-printed titanium implants for facial reconstruction

  This study tests whether custom-made 3D-printed titanium facial implants can improve reconstruction and appearance for adults with facial bone defects or asymmetry.

  Recruiting Latakia University · Latakia · NCT07654647

• Comparing dual-energy CT and MRI for staging oral and oropharyngeal squamous cell carcinoma

  This will test whether 40 keV dual-energy CT can replace a contrast-enhanced neck and facial MRI for staging adults with oral or oropharyngeal squamous cell carcinoma.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07343271

• Sacituzumab govitecan plus cetuximab for recurrent or metastatic head and neck squamous cell cancer

  This trial will test whether combining sacituzumab govitecan with cetuximab works and is safe for people whose head and neck squamous cell cancer has returned or spread after prior immunotherapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07063212

• Pre-surgery metronidazole and chlorhexidine to lower bacteria in oral cavity tumors

  This study will try a short course of the antibiotic metronidazole plus chlorhexidine mouthwash before surgery to see if it lowers bacteria inside tumors in adults with oral squamous cell carcinoma.

  Recruiting Phase 2 Case Comprehensive Cancer Center · Cleveland, Ohio · NCT06627270

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.